1919 Investment Counsel’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-381
Closed -$41K 1081
2014
Q2
$41K Hold
381
﹤0.01% 732
2014
Q1
$34K Hold
381
﹤0.01% 733
2013
Q4
$17K Hold
381
﹤0.01% 818
2013
Q3
$17K Hold
381
﹤0.01% 824
2013
Q2
$13K Buy
+381
New +$13.4K ﹤0.01% 837

1919 Investment Counsel's FURX Position: Q3 2014 in Review

1919 Investment Counsel sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 381 shares — an estimated $41K sold.

1919 Investment Counsel first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $41K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • 1919 Investment Counsel reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • 1919 Investment Counsel sold 381 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $41K.
  • 1919 Investment Counsel first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • 1919 Investment Counsel's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $41K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.